Taisho Pharmaceutical
Japanese multinational pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Taisho Pharmaceutical?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Taisho Pharmaceutical Co., Ltd. (大正製薬株式会社, Taishō Seiyaku Kabushiki-gaisha), commonly known as Taisho, is a Japanese multinational pharmaceutical company based in Tokyo.[3]
Quick Facts Native name, Romanized name ...
Native name | 大正製薬ホールディングス株式会社 |
---|---|
Romanized name | Taishō Seiyaku Hōrudingusu kabushiki gaisha |
Company type | Public KK |
TYO: 4581 | |
ISIN | JP3442850008 |
Industry | Pharmaceuticals |
Founded | October 12, 1912; 111 years ago (1912-10-12) |
Headquarters | Toshima-ku, Tokyo 170-8655 , Japan |
Area served | Worldwide |
Key people | Akira Uehara (President and CEO) |
Products | |
Revenue | JPY 280 billion (FY 2017) (US$ 2.6 billion) (FY 20177) |
JPY 31.6 billion (FY 2017) (US$ 298 million) (FY 2017) | |
Owner | Uehara family (33.52%) |
Number of employees | 6,340 (consolidated, as of March 31, 2018) |
Website | www.taisho.co.jp |
Footnotes / references [1][2][3] |
Close